OVERSEA CHINESE BANKING Corp Ltd Has $1.19 Million Stake in HCA Healthcare, Inc. (NYSE:HCA)

OVERSEA CHINESE BANKING Corp Ltd increased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 23.2% in the third quarter, Holdings Channel.com reports. The firm owned 2,923 shares of the company’s stock after purchasing an additional 550 shares during the quarter. OVERSEA CHINESE BANKING Corp Ltd’s holdings in HCA Healthcare were worth $1,188,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Sei Investments Co. increased its holdings in HCA Healthcare by 20.0% during the 1st quarter. Sei Investments Co. now owns 55,163 shares of the company’s stock worth $18,397,000 after purchasing an additional 9,211 shares in the last quarter. US Bancorp DE boosted its position in HCA Healthcare by 6.7% during the 1st quarter. US Bancorp DE now owns 9,127 shares of the company’s stock worth $3,044,000 after acquiring an additional 570 shares during the last quarter. Avantax Advisory Services Inc. raised its holdings in shares of HCA Healthcare by 11.0% in the first quarter. Avantax Advisory Services Inc. now owns 5,184 shares of the company’s stock valued at $1,729,000 after purchasing an additional 515 shares during the last quarter. State Board of Administration of Florida Retirement System grew its position in HCA Healthcare by 14.0% in the first quarter. State Board of Administration of Florida Retirement System now owns 243,131 shares of the company’s stock valued at $81,091,000 after purchasing an additional 29,839 shares in the last quarter. Finally, Angeles Wealth Management LLC bought a new stake in HCA Healthcare during the 1st quarter worth about $203,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Buying and Selling

In other news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the transaction, the executive vice president now directly owns 29,678 shares in the company, valued at approximately $11,438,494.76. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.70% of the stock is currently owned by company insiders.

HCA Healthcare Stock Performance

Shares of NYSE:HCA opened at $350.35 on Wednesday. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The firm has a market cap of $88.74 billion, a PE ratio of 15.73, a PEG ratio of 1.36 and a beta of 1.68. The company’s 50 day moving average price is $388.86 and its two-hundred day moving average price is $356.86. HCA Healthcare, Inc. has a 12-month low of $229.28 and a 12-month high of $417.14.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be issued a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 0.75%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.85%.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the company. Royal Bank of Canada increased their price target on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research report on Friday, August 23rd. Morgan Stanley started coverage on shares of HCA Healthcare in a research note on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 target price for the company. StockNews.com cut shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. TD Cowen cut their target price on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research note on Monday, October 28th. Finally, Wolfe Research upgraded HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. Five investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and an average target price of $385.00.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.